Viewing Study NCT02499627


Ignite Creation Date: 2026-03-26 @ 3:21 PM
Ignite Modification Date: 2026-04-23 @ 11:09 PM
Study NCT ID: NCT02499627
Status: TERMINATED
Last Update Posted: 2021-05-27
First Post: 2015-07-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bendamustine Plus Brentuximab Vedotin in HL and CD30+ PTCL in First Salvage Setting
Sponsor: Fondazione Italiana Linfomi - ETS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module